Angiotensin II type 1 receptor A/C1166 polymorphism: Relationships with blood pressure and cardiovascular structure

Hypertension

Volumn 28, Issue 6, 1996, Pages 1076-1080

  Castellano, Maurizio ^a   Muiesan, Maria Lorenza ^a   Beschi, Marina ^a   Rizzoni, Damiano ^a   Cinelli, Angelo ^a   Salvetti, Massimo ^a   Pasini, Gianfranco ^a   Porteri, Enzo ^a   Bettoni, Giorgio ^a   Zulli, Roberto ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

blood pressure; hypertrophy; polymorphism, genetic; receptors, angiotensin

Indexed keywords

ANGIOTENSIN RECEPTOR; CHOLESTEROL; DNA; GLUCOSE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FAMILY HISTORY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 10544245677     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.1076     Document Type: Article

References (16)

1. Smith RD, Timmermans PBMWM. Human angiotensin receptor subtypes. Curr Opin Nephrol Hypertens. 1994;3:112-122.
2. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension. 1994;24:63-69.
3. Furuta H, Deng-Fu G, Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type I receptor. Biochem Biophys Res Commun. 1992;183:8-13.
4. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, Poirier O, Soubrier F, Safar M, Cambien F. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension. 1995;26:44-47.
5. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetière P, Soubrier F, Cambien F. Synergistic effect of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910-913.
6. Sahn D, DeMaria A, Kisslo J, Weyman AE. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography. Circulation. 1978;58:1072-1083.
7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-Dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Sm Echocardiogr. 1989;2: 358-367.
8. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller D, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardial. 1984;4:1222-1230.
9. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
10. Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the Steering Committee. American Heart Association. Hypertension. 1988;11:209A-222A.
11. Parati G, Bosi S, Castellano M, Cristofari M, Di Rienzo M, Germanò G, Lattuada S, Mormino P, Mos L, Omboni S, Palatini P, Ravogli A, Rizzoni D, Verdecchia P, Zito M. Guidelines for 24-h non-invasive ambulatory blood pressure monitoring: report from a working group of the Italian Society of Hypertension. High Blood Pressure. 1995;4:168-174.
12. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland. Arteriosclerosis. 1988;8:788-792.
13. Susser M. What is a cause and how we know one: a grammar for practical epidemiology. Am J Epidemiol. 1991;133:635-648.
14. Bonithon-Kopp C, Ducimetière P, Touboul P-J, Fève J-M, Billaud E, Courbon D, Héraud V. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994;9:952-954.
15. Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porteri E, Bettoni G, Kreutz R, Lindpaintner K, Agabiti Rosei E. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: The Vobarno Study. Circulation. 1995;91:2721-2724.
16. Laurent S. Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension. 1995;26:355-362.